Skip to content
  1. Home/
  2. Latest news/
  3. Innovation/
  4. Nod™: The digital coach designed to help your baby sleep better
Nod Mom-Baby video capture

Nod™: The digital coach designed to help your baby sleep better

Is your little one keeping you up at night? This new app could help answer some of your late-night “I need more sleep!” prayers.

It’s a question that has mystified new parents since the dawn of time: “How in the world do I get this child to go to sleep?”
Thanks to novel 21st-century technology—and a partnership between Johnson & Johnson Consumer Inc. and Rest Devices, Inc., makers of the Mimo™ Baby Monitor—the answer (and those much-needed Zzzzs) could now be far less elusive.

It’s a collaboration that marries technology and expert coaching from JOHNSON’S® BEDTIME® Baby Sleep App with analytics from Mimo™'s infant sleep wearables and crib monitors to produce a new app called Nod™.

The goal: Both companies have studied hundreds of thousands of baby sleep patterns, so by combining their expertise, the Nod™ app can provide parents with an advanced, personalized sleep coaching system—like having a baby sleep expert in your own home.

The app debuts at the Consumer Electronics Show in Las Vegas this week. In anticipation, we tapped Russel Walters, Research Fellow of Biophysics and Modeling at Johnson & Johnson; sleep expert Jodi Mindell, Ph.D., CBSM; and Dulcie Madden, Co-founder and CEO of Rest Devices, Inc., to walk us through the groundbreaking technology.

1775614113001-5270880003001-5270841823001-vs.jpg
nod_3_ƒ

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.